GABA Therapeutics and ATAI Life Sciences to develop GRX-917 for the treatment of mood disorders Sep. 25, 2019
Crysvita approved in Japan for FGF-23-related hypophosphatemic rickets and osteomalacia Sep. 23, 2019
Immune responses, tumor reductions observed with Bria-IMT and pembrolizumab in phase I/IIa study Sep. 23, 2019
Beijing Scitech-Mq Pharmaceuticals patents wild-type EGFR, EGFR T790M mutant and HER2 inhibitors Sep. 23, 2019
RSS